Going back a few years, but worth documenting. Alternative link

[2022], Pfizer forecasts it will generate $29bn from the vaccine, based on contracts it had already signed in mid-October. In an earnings call in February 2021, Pfizer predicted that after the pandemic ends, its current margins — in the high 20 percentage points — will increase, as costs are likely to fall.

“There’s a significant opportunity for those margins to improve once we get beyond the pandemic environment that we’re in,” said Frank D’Amelio, chief financial officer.

…

Winnie Byanyima, the Ugandan who runs the UN’s global effort to end Aids, shuddered when she read that interview. “He hasn’t saved the world. He could have done it but he hasn’t,” she says, pointing to the very low vaccination rates in Africa.

…

Yet even if that makes the doses more affordable, many leaders feel Pfizer is forcing them to navigate a labyrinth in order to obtain them. While western leaders had Bourla on speed dial, the first challenge for some nations was getting his — or anyone at Pfizer’s — ear.

“Countries reported to us that they had been trying to get hold of Pfizer and no one returned their calls,” says a person familiar with the African Union’s vaccine-purchasing operation.

Before deals could be agreed, Pfizer demanded countries change national laws to protect vaccine makers from lawsuits, which many western jurisdictions already had. From Lebanon to the Philippines, national governments changed laws to guarantee their supply of vaccines.

Jarbas Barbosa, the assistant director of the Pan American Health Organization, says Pfizer’s conditions were “abusive, during a time when due to the emergency [governments] have no space to say no”.